Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed September 25, 2026.
Oncobox offers a groundbreaking solution for effective cancer therapy based on deep tumor molecular profiling, evaluating the effectiveness of 170 novel targeted and immunotherapy drugs to assist healthcare providers in crafting highly effective, personalized treatment plans. Every tumor is unique, and Oncobox Dx considers all molecular nuances to tailor treatment.
AI did not recommend this brand in the limited public category test.
Optimly has not yet published a supported competitor set for Oncobox.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Official website: https://oncobox.com/
Last analyzed: September 25, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile